濟川藥業(600566.SH):擬使用銀行承兑匯票支付募投項目並以募集資金等額置換
格隆匯 10 月 12日丨濟川藥業(600566.SH)公佈,公司於2020年10月12日召開公司第九屆董事會第五次會議,審議通過了《關於使用銀行承兑匯票支付募投項目資金並以募集資金等額置換的議案》,公司決定在本次非公開發行股票募集資金投資項目(以下簡稱“募投項目”)實施期間,根據實際情況使用銀行承兑匯票支付(或背書轉讓支付)募投項目資金,並以募集資金等額置換。
公司及募投項目實施主體濟川有限、濟川醫學、東科製藥使用銀行承兑匯票支付募投項目應付設備及材料採購款、工程款等,同時以募集資金等額進行置換,將有利於加快票據週轉,提高募集資金的使用效率,降低資金使用成本,符合公司及股東的利益,不影響公司募投項目的正常進行,不存在變相改變募集資金投向和損害股東利益的情形。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.